Trial Outcomes & Findings for Performance Evaluation of Blood Glucose Monitoring System Using ISO Study Design (NCT NCT01575080)
NCT ID: NCT01575080
Last Updated: 2016-02-29
Results Overview
Untrained subjects with diabetes self-test fingerstick blood using the Blood Glucose Monitoring System (BGMS). BGMS results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI Analyzer BG results are used to calculate the number of BGMS results within +/- 15mg/dL (\<100mg/dL YSI capillary plasma) or +/- 15% (\>=100mg/dL YSI capillary plasma).
COMPLETED
NA
102 participants
1 hour
2016-02-29
Participant Flow
Participant milestones
| Measure |
Intended Users of the Monitoring System
Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.
|
|---|---|
|
Overall Study
STARTED
|
102
|
|
Overall Study
COMPLETED
|
102
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Performance Evaluation of Blood Glucose Monitoring System Using ISO Study Design
Baseline characteristics by cohort
| Measure |
Intended Users of the Monitoring System
n=102 Participants
Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.
|
|---|---|
|
Age, Continuous
|
55 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
53 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
49 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
102 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1 hourPopulation: 102 untrained subjects tested one test strip lot on the Contour TS Blood Glucose Monitoring System.
Untrained subjects with diabetes self-test fingerstick blood using the Blood Glucose Monitoring System (BGMS). BGMS results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI Analyzer BG results are used to calculate the number of BGMS results within +/- 15mg/dL (\<100mg/dL YSI capillary plasma) or +/- 15% (\>=100mg/dL YSI capillary plasma).
Outcome measures
| Measure |
Intended Users of the Monitoring System
n=102 BG test results
Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.
|
|---|---|
|
Number of Self-Test Fingerstick Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method
|
84 Number of BG Test Results
|
SECONDARY outcome
Timeframe: 1 hourPopulation: 102 untrained subjects tested one test strip lot on the Contour TS Blood Glucose Monitoring System
Untrained subjects with diabetes self-test Alternative Site (AST) Palm blood using the Blood Glucose Monitoring System (BGMS). BGMS AST palm results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results are used to calculate the number of AST palm BGMS results within +/- 15mg/dL (\<100mg/dL YSI capillary plasma) or +/- 15% (\>=100mg/dL YSI capillary plasma).
Outcome measures
| Measure |
Intended Users of the Monitoring System
n=102 BG test results
Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.
|
|---|---|
|
Number of Self-Test Alternative Site (Palm) Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method
|
78 Number of BG Test Results
|
SECONDARY outcome
Timeframe: 1 hourPopulation: 102 untrained subjects tested one test strip lot using the Contour TS BG Monitoring System. One subject was unable to obtain sufficient sample volume to test. Another subject's meter displayed
Untrained subjects with diabetes self-test Alternative Site (AST) Forearm blood using the Blood Glucose Monitoring System (BGMS). BGMS AST forearm results are compared with capillary plasma BG results obtained with a Yellow Springs Instrument (YSI) Analyzer. YSI capillary plasma BG results are used to calculate the number of AST forearm BGMS results within +/- 15mg/dL (\<100mg/dL YSI capillary plasma) or +/- 15% (\>=100mg/dL YSI capillary plasma).
Outcome measures
| Measure |
Intended Users of the Monitoring System
n=100 BG test results
Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.
|
|---|---|
|
Number of Self-Test Alternative Site (Forearm) Blood Glucose Results Within +/- 15mg/dL (<100mg/dL) or Within +/- 15% (>=100mg/dL) of Laboratory Glucose Method
|
83 Number of BG Test Results
|
SECONDARY outcome
Timeframe: 1 hourSubjects will complete short questionnaires to provide feedback on the labeling materials and system ease of use. Subjects may respond 'Strongly Agree' 'Agree' 'Neutral' 'Disagree' 'Strongly Disagree'.
Outcome measures
| Measure |
Intended Users of the Monitoring System
n=102 Participants
Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.
|
|---|---|
|
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements
I found it easy to do a blood test w this meter
|
98 participants
|
|
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements
Meter display (test result) is easy to read
|
102 participants
|
|
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements
Easy to see and understand the test results
|
101 participants
|
|
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements
I like the overall meter design
|
80 participants
|
|
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements
Meter is easy to handle
|
90 participants
|
|
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements
Easy to handle the individual test strips
|
64 participants
|
|
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements
Instructions (User Guide) easy to understand
|
97 participants
|
|
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements
Instructions clearly explain how to run a test
|
101 participants
|
|
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements
Instructions clearly explain meter error message
|
98 participants
|
|
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements
I found this meter easy to use
|
100 participants
|
|
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements
I found this meter intuitive
|
96 participants
|
|
Number of Subject Responses That 'Agree' or 'Strongly Agree' With Questionnaire Statements
I found this meter practical
|
97 participants
|
Adverse Events
Intended Users of the Monitoring System
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Intended Users of the Monitoring System
n=102 participants at risk
Untrained subjects with diabetes use Contour TS Blood Glucose Monitoring System.
|
|---|---|
|
Endocrine disorders
hypoglycemia
|
2.0%
2/102 • Number of events 2
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place